Polymorphonuclear leukocyte integrins in deep venous thrombosis

Clinical and Applied Thrombosis/Hemostasis

Volumn 11, Issue 1, 2005, Pages 95-97

  Caimi, Gregorio ^a,b   Canino, B ^a   Ferrara, F ^a   Montana, M ^a   Lo Presti, R ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b NONE   (Italy)

Author keywords

Deep venous thrombosis; Polymorphonuclear leukocyte activation; Polymorphonuclear leukocyte integrins

Indexed keywords

BETA2 INTEGRIN; CD11B ANTIGEN; CELL ADHESION MOLECULE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; GLYCOPROTEIN P 15095; INTEGRIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MONOCLONAL ANTIBODY; PHORBOL 13 ACETATE 12 MYRISTATE; POLYMORPHONUCLEAR LEUKOCYTE INTEGRIN; UNCLASSIFIED DRUG;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; COLOR ULTRASOUND FLOWMETRY; CYTOFLUOROMETRY; DEEP VEIN THROMBOSIS; FEMALE; FLOW CYTOMETRY; HUMAN; LEUKOCYTE ACTIVATION; MALE; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; VEIN THROMBOSIS;

FEMALE; HUMANS; INTEGRINS; MALE; MIDDLE AGED; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; TETRADECANOYLPHORBOL ACETATE; VENOUS THROMBOSIS;

EID: 13244260853     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602960501100112     Document Type: Article

References (14)

1. Stewart GJ. Neutrophils and deep venous thrombosis. Haemostasis 1993;23:127.
2. Whiston RJ, Hallett MB, Davies EV, et al. Inappropriate neutrophil activation in venous disease. Br J Surg 1994;81:695.
3. Downing LJ, Strieter RM, Kadell AM, et al. Neutrophils are the initial cell type identified in deep venous thrombosis induced vein wall inflammation. ASAIO J 1996;42:M677.
4. Wakefield TW, Strieter RM, Prince MR, et al. Pathogenesis of venous thrombosis: A new insight. Cardiovasc Surg 1997;5:6.
5. Reiter M, Bucek RA, Koca N, et al. Deep vein thrombosis and systemic inflammatory response: A pilot trial. Wien Klin Wochenschr 2003;115:111.
6. Wakefield TW, Strieter RM, Wilke CA, et al. Venous thrombosis-associated inflammation and attenuation with neutralizing antibodies to cytokines and adhesion molecules. Arterioscler Thromb Vasc Biol 1995;15:258.
7. Wakefield TW, Strieter RM, Downing LJ, et al. P-selectin and TNF inhibition reduce venous thrombosis inflammation. J Surg Res 1996;64:26.
8. Myers DD Jr, Henke PK, Wrobleski SK, et al. P-selectin inhibition enhances thrombus resolution and decreases vein wall fibrosis in a rat model. J Vasc Surg 2002;36:928.
9. Thanaporn P, Myers DD, Wrobleski SK, et al. P-selectin inhibition decreases post-thrombotic vein wall fibrosis in a rat model. Surgery 2003;134:365.
10. Hogevold HE, Lyberg T, Kahler H, et al. Expression of beta-2-integrins and L-selectin by leukocytes and changes in acute-phase reactants in total hip replacement surgery. Eur Surg Res 1996;28:190.
11. Quarmby J, Smith A, Collins M, et al. A model of in vivo human venous thrombosis that confirms changes in the release of specific soluble cell adhesion molecules in experimental venous thrombogenesis. J Vasc Surg 1999;30:139.
12. Smith A, Quarmby JW, Collins M, et al. Changes in the levels of soluble adhesion molecules and coagulation factors in patients with deep vein thrombosis. Thromb Haemost 1999;82:1593.
13. Caimi G, Canino B, Ferrara F, et al. Leukocyte rheology before and after chemotactic activation in some venous diseases. Eur J Vasc Endovasc Surg 1999;18:411.
14. Saharay M, Shields DA, Porter JB, et al. Leukocyte activity in the microcirculation of the leg in patients with chronic venous disease. J Vasc Surg 1997;26:265.